Literature DB >> 16166955

The evolving story of the epidermal growth factor receptor as a target for non-small-cell lung cancer.

Thomas J Lynch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 16166955

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients.

Authors:  Giovanni Corso; Valeria Pascale; Giuseppe Flauti; Francesco Ferrara; Daniele Marrelli; Franco Roviello
Journal:  Eur J Hum Genet       Date:  2013-04-10       Impact factor: 4.246

2.  Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC).

Authors:  Carles Codony-Servat; Jordi Codony-Servat; Niki Karachaliou; Miguel Angel Molina; Imane Chaib; Jose Luis Ramirez; Maria de Los Llanos Gil; Flavio Solca; Trever G Bivona; Rafael Rosell
Journal:  Oncotarget       Date:  2017-07-18

3.  Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment.

Authors:  Andrei-Tudor Cernomaz; Ina Iuliana Macovei; Ionut Pavel; Carmen Grigoriu; Mihai Marinca; Florent Baty; Simona Peter; Radu Zonda; Martin Brutsche; Bogdan- Dragos Grigoriu
Journal:  BMC Pulm Med       Date:  2016-05-23       Impact factor: 3.317
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.